Minerva Surgical Inc (NASDAQ:UTRS) shares are soaring Wednesday morning after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.
The Details: Minerva Surgical was granted U.S. patent #11653972 for “Medical Systems And Methods (For Resecting And Extracting Tissue).”
The patent describes a process in which tissue is resected and extracted from a patient’s body using a tool which uses vaporization to propel the tissue through an extraction lumen of the resecting device.
“Resection is achieved using an electrosurgical electrode assembly including a first electrode on a resecting member and a second electrode within a resection probe or tool,” the patent states.
The first resecting portion involves a radio frequency current and the second portion involves vaporization of fluids by radio frequency which then propels the tissue from the device.
“In one embodiment, an extending element extends from a housing and into a channel in a resecting member as the resecting member moves toward a distal position,” the patent states.
Minerva is a commercial-stage medical technology company focused on developing, manufacturing and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women.
See Also: Why Novavax, Pfizer And BioNTech Shares Are Rising Today
UTRS Price Action: Minerva shares were up 183.4% at 52 cents at the time of writing, according to Benzinga Pro.
Photo: Lorenzo Cafaro from Pixabay.
